Home
Jagsonpal Pharmaceuticals Ltd Board of Directors
Board of Directors at Jagsonpal Pharmaceuticals Ltd
Abhishek Joshi
Company Sec. & Compli. Officer
Debasis Nandy
Independent Director
Harsha Raghavan
Chairman & Non Executive Dir.
Manish Gupta
Managing Director
Pallavi Dinodia
Independent Director
Key Highlights
- Manish Gupta joins the board as Executive Director & MD, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Harsha Raghavan joins the board as Chairperson, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Pallavi Dinodia joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Debasis Bikash Nandy joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Prithipal Singh Kochhar joins the board as Non Executive Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Jagsonpal Pharmaceuticals Ltd
NSE: JAGSNPHARM
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 24 Oct 2025 | 216.1 |
| 23 Oct 2025 | 219.15 |
| 21 Oct 2025 | 221.85 |
| 20 Oct 2025 | 217.35 |
| 17 Oct 2025 | 220.5 |
| 16 Oct 2025 | 219.7 |
| 15 Oct 2025 | 223.45 |
| 14 Oct 2025 | 211.7 |
| 13 Oct 2025 | 216.05 |
| 10 Oct 2025 | 220.65 |
Company Fundamentals for Jagsonpal Pharmaceuticals Ltd
Market Cap
1,441 Cr
EPS
6.4
P/E Ratio (TTM)
33.8
P/B Ratio (TTM)
6.0
Day’s High
219.1
Day’s Low
215.4
DTE
0.0
ROE
16.6
52 Week High
328.02
52 Week Low
176.04
ROCE
20.4
Market Price of Jagsonpal Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Jagsonpal Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Jagsonpal Pharmaceuticals Ltd News Hub
Jagsonpal Pharmaceuticals AGM scheduled
Jagsonpal Pharmaceuticals announced that the 45th Annual General Meeting (AGM) of the company will b
Read more
13 Aug 24
Jagsonpal Pharmaceuticals standalone net profit declines 28.74% in the June 2024 quarter
Net profit of Jagsonpal Pharmaceuticals declined 28.74% to Rs 5.33 crore in the quarter ended June 2
Read more
08 Aug 24
Jagsonpal Pharmaceuticals declare Quarterly Result
Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 August 2
Read more
01 Aug 24
Jagsonpal Pharmaceuticals to table results
Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23 October
Read more
17 Oct 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of Jagsonpal Pharmaceuticals Ltd
How are members of Jagsonpal Pharmaceuticals Ltd Board of Directors selected?
Members of the Jagsonpal Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Jagsonpal Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Jagsonpal Pharmaceuticals Ltd Board of Directors?
Shareholders can interact with the Jagsonpal Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Jagsonpal Pharmaceuticals Ltd Board of Directors meet?
The Jagsonpal Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Jagsonpal Pharmaceuticals Ltd Board of Directors?
The Jagsonpal Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Jagsonpal Pharmaceuticals Ltd?
The current Board of Directors at Jagsonpal Pharmaceuticals Ltd includes Manish Gupta( Executive Director & MD) ,Harsha Raghavan( Chairperson) ,Pallavi Dinodia( Independent Non Exe. Director) ,Debasis Bikash Nandy( Independent Non Exe. Director) ,Prithipal Singh Kochhar( Non Executive Director) . The full list can be found on Jagsonpal Pharmaceuticals Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
